5+ years of experience
Concerned about your lack of experience? Learn More...
Employment Type:
Full time
Job Category:
See more jobs for students and recent grads who studied:
Compensation Leader, Research & Development
Biogen | Cambridge, Massachusetts
Tell Us More About Your Job Preferences
By telling us what you think of this job, we can help find jobs that match your interests. If you want to see more jobs like this, click on the smiley face. Or if this job isn't what you are looking for, click the frowny face. Learn More...

Follow This Company

Job Description

External Posting TitleCompensation Leader, Research & Development
Job DescriptionThis Compensation Leader will report directly to the Head of Global Compensation and will lead all compensation activities in support of our global Research and Development (R&D) function. This position will provide thought leadership and expertise bridging compensation, Human Resources and business management to ensure that compensation and other rewards programs are best in class and effectively align to the business objectives and goals for R&D and the greater organization. The ideal candidate will be entrenched in the business priorities and collaborate to create innovative solutions to effectively support business challenges. The candidate will be an active member of the HR senior leadership team as well as the People Rewards team. Lead, participate and/or pull through corporate compensation initiatives and programs, such as the total rewards strategy review, communications, structure change considerations, incentive plan designs, and annual compensation planning to name a few.


• Provides thought leadership on compensation and related topics for unique business situations

• Determines and sets the key compensation priorities for the year by identifying opportunities for improvement, continuous innovation and by partnering with the People Rewards team and the Research and Development HR team.

• Manages all aspects of annual compensation within Research and Development including annual salary planning and bonus and LTI planning, market assessments, etc.

• Provides advice and counsel to HR business partners and senior staff on pay programs as well as policy and guideline interpretation.

• Conducts research, keeps current on best practices and provides input on recommendations on global plans and programs.

• Performs ad hoc analysis and planning to continuously improve our global compensation programs and processes.
LocationCambridge, MA, US
Job CategoryHuman Resources
Requisition Number31282BR
QualificationsThe successful candidate will have at least 7-10 years of experience as a compensation professional with progressively increasing levels of experience. Broader experience in human resources, finance or other core business functions is preferred, but not mandatory. Knowledge of jobs and compensation programs in the biotechnology or the pharmaceuticals industry is preferred, but not mandatory.


• Ability to identify and clearly communicate findings, patterns, themes and issues that are relevant to our business. Communicate complex technical solutions in a simple manner that can be understood broadly within the organization.

• Ability to consult with colleagues to identify issues, determine potential solutions, and analyze the impact on the broader organization.

• Ability to forge relationships across a range of styles and cultures to form networks within and outside the company.

• Ability to use core technology to report information, analyze data and develop analytical models

• Knowledge in overall Broad-based compensation areas (salary plans, short and long-term incentives), but able to think broadly to integrate beyond just compensation.

• Must be a self-starter with the ability to multitask, prioritize effectively and integrate with the rest of the team in a fast paced progressive environment

• Must be a creative thinker and have the courage to take calculated risks

• Strong technical and tactical skills combined with sound business acumen and keen financial and analytic ability

• Ability to assess a situation quickly and ask the right questions

• A track record of creativity and innovation

• Business and personal integrity

• Keen attention to detail and the ability to deliver a well thought out point of view
• Bachelor's degree required with preference in Business, Accounting, Mathematics or Finance

• MBA, Master's degree and CCP certification is highly desirable in a quantitative field
About BiogenCorporate Overview
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis (MS), has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). Biogen also manufactures and commercializes biosimilars of advanced biologics. Our global organization of nearly 7,000 employees is committed to a single mission: making a meaningful difference in the lives of patients with few or no treatment options.
  • Biogen was founded in 1978 and today serves patients in nearly 70 countries.
  • A Fortune 500 company, Biogen in 2016 had revenues of $11.4 billion
  • Global headquarters in Cambridge, MA, and international headquarters in Zug, Switzerland
Our Science
We aspire to have the greatest impact on patients and science of any biotechnology company in the history of our industry. To us, that means creating novel medicines that benefit individuals and society, and bringing new scientific understanding to diseases for which there are no adequate treatments.
  • For nearly two decades Biogen has led in the research and development of new therapies to treat MS, including the most prescribed oral treatment in the world. Now our research is driving revolutionary new MS treatments with the goal of reversing or even repairing damage caused by the disease.
  • We are now applying our neurological expertise to solve some of most challenging and complex diseases of the brain, including Alzheimer's disease, Parkinson's disease, and ALS.
  • As we uncover new insights into human biology, Biogen is employing cutting-edge technologies to discover potential treatments for rare and genetic disorders.
  • Biogen is revolutionizing biologics manufacturing, developing the industry's most advanced plants and processes. This expertise is used to produce both original innovative therapies and biosimilars that expand patient access to lower-cost medicines.
Our Corporate Citizenship
The same intellectual discipline and passion that drives our science is reflected in our corporate citizenship, environmental sustainability, and commitment to diversity and inclusion. As a company, we are focused on improving science education and limiting the impact of our company on the environment. In 2015, we became a carbon neutral company and ranked first place on Newsweek's 2015 Green Rankings, and we are an industry leader on the Dow Jones Sustainability World Index. Biogen was named to Science's list of Top Employers of 2015 and in 2017 received a perfect score of 100 for the fourth consecutive year on the Human Rights Campaign (HRC) Corporate Equality Index, which also named Biogen as one of its Best Places to Work.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Please be advised that all legitimate correspondence from a Biogen employee will come from "@biogen.com" email accounts.

About Biogen

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company's products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab), TYSABRI (natalizumab) and FUMADERM (dimethylfumarate and monoethylfumarate salts). AVONEX is used in the treatment of relapsing forms of multiple sclerosis (MS). RITUXAN is used in the treatment of relapsed or refractory low-grade or follicular, CD20-positive, and B-cell, non-Hodgkin's lymphomas (B-cell NHLs). TYSABRI is approved for the treatment of relapsing forms of MS. FUMADERM acts as an immunomudulator. It also has product candidates, such as BG-12 (acquired with the purchase of Fumapharm), ANTI-CD80 antibody/(galiximab), ANTI-CD23 antibody/(lumiliximab), Ocrelizumab/(Humanized ANTI-CD20 Antibody) and Lixivaptan.In January 2007, the Company completed the acquisition of Syntonix Pharmaceuticals, Inc. (Source: 10-K)

This company profile was created by AfterCollege and is about Biogen. This page is not endorsed by or affiliated with Biogen. For questions regarding company profiles, please email: care@aftercollege.com.